1. Home
  2. TWI vs CERS Comparison

TWI vs CERS Comparison

Compare TWI & CERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Titan International Inc. (DE)

TWI

Titan International Inc. (DE)

N/A

Current Price

$6.82

Market Cap

453.1M

Sector

Industrials

ML Signal

N/A

Logo Cerus Corporation

CERS

Cerus Corporation

N/A

Current Price

$2.30

Market Cap

534.0M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
TWI
CERS
Founded
1890
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Steel/Iron Ore
EDP Services
Sector
Industrials
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
453.1M
534.0M
IPO Year
1997
1996

Fundamental Metrics

Financial Performance
Metric
TWI
CERS
Price
$6.82
$2.30
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
4
Target Price
★ $12.00
$5.13
AVG Volume (30 Days)
505.9K
★ 1.5M
Earning Date
11-05-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 27.27
EPS
N/A
★ N/A
Revenue
N/A
★ $51,326,000.00
Revenue This Year
$1.95
$20.82
Revenue Next Year
$4.18
$9.02
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 30.68
52 Week Low
$6.37
$1.38
52 Week High
$11.70
$3.47

Technical Indicators

Market Signals
Indicator
TWI
CERS
Relative Strength Index (RSI) 38.72 35.19
Support Level $6.40 $2.05
Resistance Level $7.43 $2.69
Average True Range (ATR) 0.24 0.10
MACD -0.06 -0.02
Stochastic Oscillator 0.00 0.28

Price Performance

Historical Comparison
TWI
CERS

About TWI Titan International Inc. (DE)

Titan International Inc is a manufacturer of wheels, tires, wheel and tire assemblies, and undercarriage systems and components for off-highway vehicles. It designs and manufactures products for OEMs and aftermarket customers in the agricultural, earthmoving/construction, and consumer markets. The company operates through three segments, namely Agricultural, Earthmoving/Construction, and Consumer. It derives the majority of revenue from the Agricultural segment which manufactures various agricultural equipment, including tractors, combines, plows, planters and irrigation equipment. Geographically, the company generates the maximum revenue from North America, followed by Europe / CIS, Latin America, and Asia and other regions.

About CERS Cerus Corporation

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety, and generates revenue from the same.

Share on Social Networks: